Soriot said the company does hundreds of clinical trials out of its Canadian facilities and the expansion will grow that work.
“We’re building a whole ecosystem. We’re expanding our research network across universities, hospitals and research centers. We’re investing in innovations and high-performance tools and new facilities,” he said. “This investment is a huge vote of confidence in Ontario in our thriving research ecosystem with our world-class universities and colleges,” he said. “We want Ontario to be the place where medical breakthroughs are discovered, commercialized and developed into innovative products.”Article content
Duclos defended his choices, saying he was asked for his opinion and weighed in because he didn’t want the process to be rushed.Article content
Keep them out of Canada!
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Drug maker AstraZeneca to expand Canadian operations, hire hundreds of workersThe Canadian government is not helping fund the company’s $500\u002Dmillion expansion in Canada.
Source: VancouverSun - 🏆 49. / 61 Read more »
Drug maker AstraZeneca to expand Canadian operations, hire hundreds of workersThe Canadian government is not helping fund the company’s $500\u002Dmillion expansion in Canada. Shouldn't they be preparing the gallows for these drug companies? Yes…we can have home grown adverse effects now!!! Woohooo WHO'S GOING TO BUY THEIR PRODUCTS ❓❓❓❓❓❓❓
Source: nationalpost - 🏆 10. / 80 Read more »
Drug maker AstraZeneca to expand Canadian operations, hire hundreds of workersThe Canadian government is not helping fund the company’s $500\u002Dmillion expansion in Canada. Hopefully the next Conservative Prime Minister doesn't see it off to China or some other high bidder
Source: OttawaCitizen - 🏆 21. / 68 Read more »
Canadian-founded company develops first AI-designed COVID-19 drug, starts clinical trialsFor the first time ever, a drug for COVID-19 designed with artificial intelligence is headed to clinical trials. Insilico Medicine, a Hong Kong-based AI pharmaceutical company, announced last Thursday its ISM3312 therapeutic would be starting clinical trials in China after its preclinical studies found that the drug 'significantly reduces' viral load and inflammation in the lungs. Do they know it's not 2021? Because that’s a good idea… Now make everyone stick it in their arm. That would be just fantastic.
Source: CTVNews - 🏆 1. / 99 Read more »